Linde plc (LIN) — Q2 2026 Earnings Preview

Company

Linde plc

Ticker

NASDAQ: LIN

Upcoming Earnings Date

July 31, 2026 (Before Market Open)

Reporting Period

Q2 2026 (Quarter ended June 30, 2026)

Preparation Date

July 30, 2026

Last Earnings

May 1, 2026 (Q1 2026)

1. Earnings Preview

Key Takeaway: Setup is balanced-to-slightly-positive — consensus sits just above the guidance midpoint and LIN has beaten EPS in every one of the last eight quarters, but the stock has already given back its post-Q1 helium-driven spike and trades roughly flat since last earnings, suggesting the bar is not stretched. The single biggest swing factor is helium pricing and volume upside, which management has deliberately excluded from guidance and which could meaningfully surprise to the upside.

Heading into Q2 2026, the setup for Linde is modestly constructive. Consensus EPS of $4.48 sits just $0.03 above the guidance midpoint of $4.45 ($4.40–$4.50), a thin cushion that leaves room for the company's typical 1–2% beat without requiring heroics. Management's posture on the Q1 call was deliberately cautious — raising only the bottom end of full-year guidance and explicitly citing geopolitical uncertainty as the reason for holding the top end — yet the underlying business delivered 30% operating margins and positive base volume growth for the first time in several years. Estimate revisions have been essentially flat since the Q1 print, with both Q2 and FY2026 EPS consensus unchanged at $4.48 and $17.86 respectively, suggesting the Street has taken management's conservative framing at face value rather than chasing upside. The stock has underperformed both the S&P 500 (+2.9%) and the XLB materials ETF (+0.6%) since the May 1 earnings date, briefly spiking ~7.6% in early July on helium shortage headlines before fully retracing — a pattern that implies the market is not pricing in a meaningful helium windfall. The key wildcard is

helium: with China, Russia, and Qatar export disruptions creating acute global shortages and Bernstein raising its price target to $599 specifically citing the AI supply chain angle, any incremental color on helium contract signings or pricing trajectory could be the decisive catalyst for the print.

2. KPIs & Consensus Expectations

Key Takeaway: Consensus EPS of $4.48 represents a modest but achievable bar — LIN has beaten EPS in all eight of the last eight quarters. Revenue is the bigger swing factor, where LIN has been more inconsistent, though the Q1 2026 beat of +2.3% suggests underlying demand is firming.

Table 1 — Q2 2026 Current Quarter Snapshot

Source: Visible Alpha Consensus and Actuals Data; LIN Q1 2026 Earnings Call (May 1, 2026).

Table 2A — Beat/Miss History: Adjusted EPS (Last 8 Quarters)

Quarter

Reported

Consensus

Surprise %

Result

Q2 2024

$3.85

$3.79

+1.6%

Beat

Q3 2024

$3.94

$3.92

+0.5%

Beat

Q4 2024

$3.97

$3.93

+1.0%

Beat

Q1 2025

$3.95

$3.93

+0.5%

Beat

Q2 2025

$4.09

$4.03

+1.5%

Beat

Q3 2025

$4.21

$4.21

+0.0%

In-Line

Q4 2025

$4.20

$4.18

+0.5%

Beat

Q1 2026

$4.33

$4.26

+1.6%

Beat

Pattern: LIN has beaten or matched EPS consensus in all 8 of the last 8 quarters, with beats typically in the +0.5–1.6% range — a consistent but not dramatic outperformance cadence driven primarily by FX tailwinds and management actions on pricing and cost productivity. Source: Visible Alpha Consensus and Actuals Data.

Table 2B — Beat/Miss History: Total Revenue (Last 8 Quarters)

Quarter

Reported

Consensus

Surprise %

Result

Q2 2024

$8.267B

$8.289B

-0.3%

Miss

Q3 2024

$8.356B

$8.351B

+0.1%

Beat

Q4 2024

$8.282B

$8.376B

-1.1%

Miss

Q1 2025

$8.112B

$8.199B

-1.1%

Miss

Q2 2025

$8.495B

$8.350B

+1.7%

Beat

Q3 2025

$8.615B

$8.616B

0.0%

In-Line

Q4 2025

$8.764B

$8.679B

+1.0%

Beat

Q1 2026

$8.781B

$8.583B

+2.3%

Beat

Pattern: Revenue is less consistent than EPS — LIN missed in 3 of the last 8 quarters, with misses concentrated in periods of FX headwinds and weak European industrial demand. The recent trend has improved sharply, with the last three quarters all beating or matching, driven by FX tailwinds and firming volumes. Source: Visible Alpha Consensus and Actuals Data.

KPI

Q1 2026 Actual

Q2 2025 Actual (Prior Year)

Q2 2026 Consensus Est.

YoY Change

Q2 2026 Guidance

Cons. vs. Guidance Mid (%)

Adj. EPS (Diluted)

$4.33

$4.09

$4.48

+9.5%

$4.40–$4.50 (mid $4.45)

+0.7%

Total Revenue

$8.781B

$8.495B

$9.012B

+6.1%

No explicit guidance

N/A

Operating Profit (Adj.)

$2.630B

$2.556B

$2.723B

+6.5%

No explicit guidance

N/A

Operating Margin (Adj.)

30.0%

30.1%

~30.2%

~flat YoY

Upper end / above 40–60bps expansion (FY)

N/A

Free Cash Flow

$0.898B

$0.954B

$1.658B

+73.8%

No explicit guidance

N/A

Sale of Gas Backlog

$7.1B (Q1 2026 end)

$7.1B (Q2 2025 end)

N/A — not in VA

Flat YoY; mgmt targets ≥8B by year-end

Mgmt: potential “8-handle” by year-end

N/A

Key Takeaway: Consensus is a

Key Takeaway: Consensus represents a

3. Guidance & Commentary Evolution

Key Takeaway: No guidance revisions since the Q1 2026 earnings call on May 1, 2026 — the Q2 EPS range of $4.40–$4.50 and FY2026 range of $17.60–$17.90 remain intact. Management's tone is

Metric

Initial Guidance (Q1 2026 Earnings Call, May 1, 2026)

Revised Guidance

Current Consensus

Note

Q2 2026 Adj. EPS

$4.40–$4.50 (8–10% YoY growth); includes 1% FX benefit; assumes no economic improvement at midpoint

$4.48

Unchanged since Q1 earnings call. Consensus sits $0.03 above midpoint (+0.7%). Helium upside explicitly excluded.

FY2026 Adj. EPS

$17.60–$17.90 (7–9% YoY growth); raised bottom end by $0.20 from prior $17.40–$17.90; top end held flat; includes 1% FX tailwind

$17.86

Unchanged since Q1 earnings call. Mgmt cited desire for “more clarity on geopolitical events” before signaling increased optimism. Consensus near top of range.

FY2026 Operating Margin

Upper end or above traditional 40–60bps annual expansion range; confident in full-year margin raise

~30.2% (Q2 est.)

Unchanged. Q1 2026 margin was 30.0%, consistent with prior year. Management actions on pricing and cost productivity expected to continue.

Helium

Excluded from guidance entirely; framed as pure upside. Priority is securing new long-term contracts, not spot sales.

N/A

Global helium shortage has intensified since Q1 call (China ban, Russia/Qatar disruptions). Any incremental helium benefit remains unmodeled upside.

Sale of Gas Backlog

Mgmt expressed high confidence in adding substantial new projects; potential for “8-handle” ($8B+) by year-end

N/A — not in VA

Backlog was $7.1B at Q1 end. Electronics projects (>$1B in UHP plants) are key near-term additions. Watch for new project announcements on Q2 call.

Key Takeaway: Guidance has been unchanged since the Q1 2026 earnings call on May 1, 2026 — no post-earnings 8-K, conference, or investor day has revised the numbers. Management's tone remains

Key Takeaway: Guidance is unchanged since the Q1 2026 print; management's tone remains

Key Takeaway: No guidance revisions since the Q1 2026 earnings call on May 1, 2026. Management's tone is

4. Guidance vs. Estimate Revision Tracker

Key Takeaway: Estimates have been essentially

Key Takeaway: Estimates are flat since the Q1 2026 print — the Street has not chased upside despite the helium narrative, leaving consensus near the top of guidance and creating a modest but real cushion for a beat.

KPI & Period

Estimate (5 days post Q1 earnings, ~5/6/26)

Current Consensus

Estimate Δ (%)

Initial Guidance (Q1 Call)

Current Guidance

Guidance Δ

Cons. vs. Guidance Mid (%)

Adj. EPS — Q2 2026

$4.48

$4.48

0.0%

$4.40–$4.50 (mid $4.45)

$4.40–$4.50 (mid $4.45)

Unchanged

+0.7%

Adj. EPS — FY2026

$17.81

$17.86

+0.3%

$17.60–$17.90 (mid $17.75)

$17.60–$17.90 (mid $17.75)

Unchanged

+0.6%

Total Revenue — Q2 2026

$9.006B

$9.012B

+0.1%

No explicit guidance

No explicit guidance

N/A

N/A

Total Revenue — FY2026

$35.994B

$36.022B

+0.1%

No explicit guidance

No explicit guidance

N/A

N/A

Adj. EPS — FY2027

$19.407B

$19.504

+0.5%

No guidance provided

No guidance provided

N/A

N/A

Estimates have been remarkably stable since the Q1 print, with FY2026 EPS drifting up just +0.3% and Q2 EPS flat. This suggests the Street has taken management's conservative framing at face value and has not modeled any helium upside — consistent with management's own guidance exclusion. The gap between consensus ($17.86) and the guidance top end ($17.90) is only $0.04, meaning any helium contribution or FX tailwind could push the full-year number above the top of the range. Source: Visible Alpha Consensus and Actuals Data.

5. Stock Performance

Key Takeaway: LIN has

Key Takeaway: LIN has underperformed both the S&P 500 (+2.9%) and the XLB materials ETF (+0.6%) since the Q1 2026 earnings date, with the stock essentially flat (+0.1%) — the brief helium-driven spike to +7.6% in early July fully retraced, suggesting the market is not pricing in a sustained helium windfall and the stock is not stretched heading into the print.

LIN vs XLB (Materials ETF) vs S&P 500 — Indexed to 100 at Q1 2026 Earnings (May 1, 2026). Source: Yahoo Finance.

6. Peer Commentaries — Q2 2026 Read-Throughs

Key Takeaway: Q2 2026 peer reports confirm the key themes relevant to LIN:

electronics/AI demand is accelerating (ECL Global High Tech +29%, APD electronics backlog >$1.5B in 6 months),

Americas remains the strongest region while EMEA faces structural headwinds, and the

Middle East conflict continues to disrupt supply chains — all consistent with LIN's Q1 narrative and supportive of a solid Q2 print.

Air Products & Chemicals (APD) — Q3 FY2026 (Calendar Q2 2026), Reported July 30, 2026

Note: APD's fiscal Q3 2026 covers the calendar quarter ending June 30, 2026 — the same period LIN is reporting. APD is LIN's closest direct peer in industrial gases.

Dow Inc. (DOW) — Q2 2026, Reported July 23, 2026

Ecolab (ECL) — Q2 2026, Reported July 28, 2026

PPG Industries (PPG) — Q2 2026, Reported July 28, 2026

Eastman Chemical (EMN) — Q2 2026, Reported July 30, 2026

Key Takeaway: Peer commentary from Q2 2026 earnings (reported in the last 60 days) is broadly constructive for LIN —

Key Takeaway: Peers reporting Q2 2026 results confirm the key themes relevant to LIN:

Key Takeaway: Q2 2026 peer reports confirm

7. Material News & Developments

Key Takeaway: The most material post-Q1 development is the

global helium supply shock (China ban + Russia/Qatar disruptions), which has intensified since the Q1 call and represents unmodeled upside to guidance; the EUR 1.6B debt offering and a wave of analyst PT raises round out the key developments.

Key Takeaway: The most important development since Q1 earnings is the

Key Takeaway: The most important development since the Q1 2026 print is the

Key Takeaway: The most material post-Q1 development is the

8. Insider Transaction Activity

Key Takeaway: Only one insider transaction since the Q1 2026 earnings date — a discretionary open-market sale by a Director. The size is modest and not part of a 10b5-1 plan, but it is not a buy signal. No clustered buying or unusual activity; the overall insider picture is neutral.

Name

Title

Transaction Type

Shares

Value (Est.)

Transaction Date

Disclosed Date

Note

Robert L. Wood

Director

Open Market Sale

880 shares

~$435K (est. at ~$494/share)

May 14, 2026

May 18, 2026

Discretionary open-market sale; NOT a 10b5-1 plan. Modest size relative to remaining holdings (~13,583 shares post-sale). No pattern of clustered selling.

No open-market purchases by insiders since the Q1 2026 earnings date. The single sale by Director Wood is modest in size and occurred shortly after the Q1 earnings release — not unusual for a director managing personal liquidity. The absence of any insider buying is neutral, not a negative signal given LIN's consistent execution track record. Source: SEC Form 4 Filings / Insider Transaction Data.